HL and Primary Malignancies

The risk, localisation and timing of third malignancies in 3,122 five-year survivors of Hodgkin lymphoma were assessed. Patients in this cohort were diagnosed before age 51 years and received treatment between 1965 and 1995.

Following a median follow-up of 22.6 years, 832 patients had developed a second malignancy and 126 patients a third one. Among female patients, the 10-year cumulative incidence of a third malignancy was 17.1%; among male patients it was 9.2%. Patients with a second malignancy were at a higher risk of developing another malignancy. For more information, click here to read the full article.


Global Database

Information by country, region and/or subtype on treatments, clinical trials and incidence/mortality rates.

Resource Library

Over 2,000 pieces of information on lymphoma diagnosis, treatment, research, support and lifestyle.

logo europe


Have you ever attended a meeting with a lymphoma support group?




The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or
require more detailed information on the best course of treatment for you.

Our website does not host any form of advertisement. Last updated: 03/27/18. Copyright © 2018 Lymphoma Coalition. All rights reserved.